全文获取类型
收费全文 | 3544篇 |
免费 | 337篇 |
国内免费 | 3篇 |
出版年
2021年 | 62篇 |
2019年 | 53篇 |
2018年 | 55篇 |
2017年 | 37篇 |
2016年 | 54篇 |
2015年 | 113篇 |
2014年 | 144篇 |
2013年 | 183篇 |
2012年 | 204篇 |
2011年 | 189篇 |
2010年 | 128篇 |
2009年 | 94篇 |
2008年 | 151篇 |
2007年 | 142篇 |
2006年 | 126篇 |
2005年 | 127篇 |
2004年 | 97篇 |
2003年 | 110篇 |
2002年 | 100篇 |
2001年 | 111篇 |
2000年 | 112篇 |
1999年 | 107篇 |
1998年 | 52篇 |
1997年 | 31篇 |
1996年 | 39篇 |
1995年 | 35篇 |
1994年 | 41篇 |
1993年 | 29篇 |
1992年 | 56篇 |
1991年 | 55篇 |
1990年 | 64篇 |
1989年 | 63篇 |
1988年 | 59篇 |
1987年 | 52篇 |
1986年 | 54篇 |
1985年 | 54篇 |
1984年 | 44篇 |
1983年 | 34篇 |
1982年 | 37篇 |
1980年 | 28篇 |
1979年 | 29篇 |
1978年 | 41篇 |
1976年 | 36篇 |
1975年 | 38篇 |
1974年 | 36篇 |
1973年 | 30篇 |
1972年 | 33篇 |
1971年 | 37篇 |
1970年 | 32篇 |
1969年 | 35篇 |
排序方式: 共有3884条查询结果,搜索用时 156 毫秒
1.
Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. 总被引:11,自引:0,他引:11
J Bauer S Strauss U Schreiter-Gasser U Ganter P Schlegel I Witt B Yolk M Berger 《FEBS letters》1991,285(1):111-114
Recent studies indicated that the formation of a major constituent of Alzheimer's disease (AD) senile plaques, called beta A4-peptide, does not result from normal processing of its precursor, amyloid precursor protein (APP). Since proteolytic cleavage of APP inside its beta A4 sequence was found to be part of APP processing the formation of the beta A4-peptide seems to be prevented under normal conditions. We considered whether in AD one of the endogenous proteinase inhibitors might interfere with APP processing. After we had recently found that cultured human neuronal cells synthesize the most potent of the known human proteinase inhibitors, alpha-2-macroglobulin (alpha 2M), upon stimulation with the inflammatory mediator interleukin-6 (IL-6) we now investigated whether alpha 2M and IL-6 could be detected in AD brains. Here we report that AD cortical senile plaques display strong alpha 2M and IL-6 immunoreactivity while no such immunoreactivity was found in age-matched control brains. Strong perinuclear alpha 2M immunoreactivity in hippocampal CA1 neurons of Alzheimer's disease brains indicates that neuronal cells are the site of alpha 2M synthesis in AD brains. We did not detect elevated IL-6 or alpha 2M levels in the cerebrospinal fluid of AD patients. Our data indicate that a sequence of immunological events which seem to be restricted to the local cortical environment is part of AD pathology. 相似文献
2.
3.
N Brinkmann M Malissard M Ramuz U R?mer T Schumacher E G Berger L Elling C Wandrey A Liese 《Bioorganic & medicinal chemistry letters》2001,11(18):2503-2506
The alpha-Gal trisaccharide Gal(alpha)(1-->3)Galbeta(1-->4)GlcNAc 11 was synthesized on a homogeneously soluble polymeric support (polyethylene glycol, PEG) by use of a multi-enzyme system consisting of beta-1,4-galactosyltransferase (EC 2.4.1.38), alpha-1,3-galactosyltransferase (EC 2.4.1.151), sucrose synthase (EC 2.4.1.13) and UDP-glucose-4-epimerase (EC 5.1.3.2). In addition workup was simplified by use of dia-ultrafiltration. Thus the advantages of classic chemistry/enzymology and solid-phase synthesis could be united in one. Subsequent hydrogenolytic cleavage afforded the free alpha-Gal trisaccharide. 相似文献
4.
5.
6.
A Tichelli A Gratwohl C Berger A Lori A Würsch A Dieterle C Thomssen C Nissen E Holdener B Speck 《Blut》1989,58(1):15-19
In an open prospective pilot trial, we tested the effect of recombinant interferon alpha-2 a (rIFN alpha-2 a) on thrombocytosis in myeloproliferative disorders (MPD). Since October 1986, 13 patients with MPD (4 with chronic granulocytic leukemia, 4 with polycythemia vera, 3 with essential thrombocythemia and 2 with myeloid metaplasia) were treated with rIFN alpha-2 a. Platelet counts decreased in all treated patients within 2 to 10 weeks from a median value of 1,050 x 10(9)/l (range 610-1,940 x 10(9)/l) to 340 x 10(9)/l (range 230-495 x 10(9)/l). The response was dose-dependent. In 11 patients we observed a simultaneous reduction of the white blood cell count. Six patients still continue the IFN alpha-2 a therapy. In 7 treatment was discontinued, because of chronic side effects in 3, and because of noncompliance in one. In these patients, thrombocytosis recurred after discontinuation of the therapy. These results show that rIFN alpha-2 a is effective in controlling thrombocytosis in MPD. However, the long-term benefit of interferon in these disorders remains to be established. 相似文献
7.
8.
9.
10.